Alzheimer’s’ BREAKTHROUGH Revolutionizes Early Detection
If you end up with Alzheimer’s, the earlier you get diagnosed, the better.
Earlier diagnosis means you can start treatments sooner, which can help slow the disease’s progression.
It also allows you to be more involved in personal decisions, gives you time to educate and prepare yourself and your family, and potentially helps you take advantage of clinical trials and other medical advances.
But diagnosing Alzheimer’s is complex.
It currently requires a combination of brain imaging, neurological exams, mental status tests, and more.
But all that may be about to change…
When it comes to Alzheimer’s, breakthroughs are typically few and far between. But boy, do we have a DOOZY on the horizon.
Researchers are working on a simple blood test for diagnosing Alzheimer’s disease with remarkable accuracy.
In a recent study, researchers found that a buildup of p-tau217 can accurately identify the presence of Alzheimer’s disease.
In a study of people with and without cognitive impairment, blood testing results showed that the largest change in p-tau217 was in those who tested positive for it plus beta-amyloid.
This test called the ALZpath p-tau217 assay, accurately identified p-tau217 up to 97 percent of the time and elevated beta-amyloid 96 percent of the time.
This means this non-invasive test is every bit as accurate as more invasive diagnostic measures.
It’s not available yet, but researchers say this test should be soon for an estimated cost of $200-$500. I’ll be sure to keep you updated with any new developments.
In the meantime, be sure to take steps to REDUCE your Alzheimer’s risk. Recent research linked a traditional whole foods diet to a significantly reduced risk of the disease.
Ditch the ultra-processed foods and added sugars. And focus on eating more fruits, vegetables, and whole grains.
P.S. Breakthrough Alzheimer’s fix shifts focus from the brain.
Source:
Ashton NJ, Brum WS, Di Molfetta G, et al. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol. Published online January 22, 2024. doi:10. 1001 /jamaneurol. 2023.5319
